A Business and Clinical Case for Continuous Surveillance: HIMSS 2019

Presentation at HIMSS 2019:

“Increased utilization of patient-controlled analgesia (PCA) and pro re nata (PRN) opioids for post-operative pain management poses significant risk of respiratory depression, particularly in patients diagnosed with or at risk for obstructive or central sleep apnea. Current practices for monitoring opioid-induced patients are neither adequate nor comprehensive. The speakers will analyze the results of two studies on the use of continuous capnography monitoring in a medical-surgical unit at a multi-hospital health system in order to detect adverse clinical events while also mitigating artifacts related to patient movement, suspect measurements and other medical device-generated alarm signals. Combining analysis with real-time data at the point of collection creates a powerful tool for prediction and clinical decision support and has implications for achieving real-time healthcare capabilities enterprise-wide.”